FDA clears hypertension drug for children, teens

FDA clears hypertension drug for children, teens7

Daiichi Sankyo Inc. announced today that the U.S. Food and Drug Administration has approved the hypertension treatment Benicar (olmesartan medoxomil) for children and adolescents aged 6 to 16 years. Benicar was originally approved in 2002 to treat hypertension in adults.